Original Medicare Has No Out-of-Pocket Cap — Cancer Costs Can Spiral

Here's a financial risk most people don't see coming until it's too late: Original Medicare — the federal health coverage tens of millions of Americans rely on — carries zero out-of-pocket maximum. That means if you're hit with a serious diagnosis like cancer, that standard 20% coinsurance doesn't stop at some comfortable ceiling. It just keeps climbing.

For a typical outpatient procedure or routine doctor visit, 20% feels manageable. But cancer treatment is a different beast entirely. Chemotherapy, radiation, specialist visits, imaging, lab work — the bills stack fast. When your total medical spend runs into the hundreds of thousands, your 20% slice becomes a number that can genuinely wreck a retirement plan.

Read more Fidelity Wants a Death Certificate From Your Ex's Family? Here's Why →

This is the structural gap that separates Original Medicare (Parts A and B) from private insurance. Employer-sponsored plans and ACA marketplace coverage are required to cap your annual out-of-pocket exposure. Medicare Advantage plans — the private alternative to Original Medicare — also carry out-of-pocket limits. But if you're on traditional Medicare and skipped a Medigap supplement policy, you're riding without a safety net.

The tradeable angle here is straightforward: this risk hits hardest at exactly the age when most people are drawing down savings rather than building them. A single serious illness year can force portfolio liquidations at the worst possible time, locking in losses and disrupting retirement income sequencing. If you or someone close to you is approaching Medicare age, the decision between Original Medicare plus Medigap versus Medicare Advantage deserves real scrutiny — not a five-minute checkbox.

Bottom line: uncapped liability is a position no trader would hold voluntarily. Don't hold it in your healthcare coverage either. Continue reading at Yahoo Finance.